Stereotactic radiotherapy for nAMD: areas for improvement – Authors' reply立体定向放射治疗用于nAMD：改进领域——作者回复lancetIF02025-07-030PRE
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trialLANCETIF88.52024-07-011OAAI
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trialBRITISH JOURNAL OF OPHTHALMOLOGYIF3.52022-02-250PRE
Intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: a randomised, double-masked, placebo-controlled feasibility study.ACTA OPHTHALMOLOGICAIF2.82019-11-011OAAI
Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literatureACTA OPHTHALMOLOGICAIF2.82017-08-3117OAAI
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT) A Phase 3 Randomized Controlled TrialOPHTHALMOLOGYIF9.52016-06-0113OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项